186Re-labeled Monoclonal Antibody E48 Immunoglobulin G-mediated Therapy of Human Head and Neck Squamous Cell Carcinoma Xenografts

Cancer Research

Volumn 53, Issue 15, 1993, Pages 3524-3529

  Meijer, Chris J L M ^a   Walsum, Marijke van ^a   Snow, Gordon B ^a   van Dongen, Guus A M S ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; MONOCLONAL ANTIBODY; RADIOISOTOPE; RHENIUM;

ANIMAL; ARTICLE; CANCER TRANSPLANTATION; FEMALE; HEAD AND NECK TUMOR; HUMAN; MOUSE; RADIATION DOSE; RADIOIMMUNOTHERAPY; SQUAMOUS CELL CARCINOMA; XENOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; HEAD AND NECK CANCER; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR REGRESSION; TUMOR VOLUME;

ANIMAL; ANTIBODIES, MONOCLONAL; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HUMAN; IMMUNOGLOBULIN G; MICE; NEOPLASM TRANSPLANTATION; RADIOIMMUNOTHERAPY; RADIOISOTOPES; RADIOTHERAPY DOSAGE; RHENIUM; SUPPORT, NON-U.S. GOV'T; TRANSPLANTATION, HETEROLOGOUS;

EID: 0027337823     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Choksi, A.J., Dimery, I.W., and Hong, W.K. Adjuvant chemotherapy of head and neck cancer: the past, the present and the future. Semin. Oncol., 15: 45s-49s, 1988.
2. Cognetti, E.V., Pinnaro, P., Carlini, P., Ruggeri, E.M., Impiobato, F.A., Rosario Del Vecchio, M., Gianarelli, D., and Perrino, A. Neoadjuvant chemotherapy in previously untreated patients with advanced head and neck squamous cell cancer. Cancer (Phi-la.), 62: 251-261, 1988.
3. Wessels, B.W., Harisiadis, L., and Carabell, S.C. Dosimetry and radiobiological efficacy of clinical radioimmunotherapy. J. Nucl. Med., 30: 827, 1989.
4. Lee, Y.C.C., Washburn, L.C., Sun, T.T., Byrd, B.L., Crook, J.E., Holloway, E.C., and Steplewski, Z. Radioimmunotherapy of human colorectal carcinoma xenografts using 90Y-labeled monoclonal antibody CO17-1A prepared by two bifunctional chelating techniques. Cancer Res., 50: 4546-4551, 1990.
5. Lee, Y.S., Bullard, D.E., Zalutsky, M.R., Coleman, R.E., Wikstrand, C.J., Friedman, H.S., Colapinto, E.V., and Bigner, D.D. Therapeutic efficacy of antiglioma mesenchymal extracellular matrix 131 I-labeled murine monoclonal antibody in a human glioma xenograft model. Cancer Res., 48: 559-566, 1988.
6. Ward, B., Mather, S., Shepherd, J., Crowther, M., Hawkins, L., Britton, K., and Slevin, M.L. The treatment of intraperitoneal malignant disease with monoclonal antibody guided 131I radiotherapy. Br. J. Cancer, 58: 658-662, 1988.
7. Smith, A., Groscurth, P., Waibel, R., Westera, G., and Stahel, R.A. Imaging and therapy of small cell carcinoma xenografts using 131I-labeled monoclonal antibody SWA11. Cancer Res., 50: 980s-984s, 1990.
8. Senekowitsch, R., Reidel, G., Mollenstadt, S., Kriegel, H., and Pabst, H.W. Curative radioimmunotherapy of human mammary carcinoma xenografts with iodine-131-labeled monoclonal antibodies. J. Nucl. Med., 30: 531-537, 1989.
9. Chiou, R.K., Vessella, R.L., Limas, C., Shafer, R.B., Elson, M.K., Arfman, E.W., and Lange, P.H. Monoclonal antibody-targeted radiotherapy of renal cell carcinoma using the nude mouse model. Cancer (Phila.), 61: 1766-1775, 1988.
10. Rosen, S.T., Zimmer, A.M., Goldman-Leikin, R., Gordon, L.I., Kazikiewicz, J.M., Kaplan, E.H., Variakojis, D., Marder, R.J., Dykewicz, M.S., Piergies, A., Silverstein, E.A., Roenigk, H.H., and Spies, S.M. Radioimmunodetection and radioimmunotherapy of cutaneous T cell lymphomas using an 131I-labeled monoclonal antibody: an Illinois Cancer Council Study. J. Clin. Oncol., 5: 562-573, 1987.
11. Britton, K.E., Buraggi, G.L., Bares, R., Bischof-Delaloye, A., Buell, U., Emrich, D., and Granowska, M. A brief guide to the practice of radioimmunoscintigraphy and radioimmunotherapy in cancer. Report of the European Association of Nuclear Medicine Task Group on the clinical utility of radiolabeled antibodies. Int. J. Biol. Markers, 4: 106-118, 1989.
12. Quak, J.J., Balm, A.J.M., van Dongen, G.A.M.S., Brakkee, J.G.P., Scheper, R.J., Snow, G.B., and Meijer, C.J.L.M. A 22-kd surface antigen detected by monoclonal antibody E48 is exclusively expressed in stratified and transitional epithelia. Am. J. Pathol., 136: 191-197, 1990.
13. Quak, J.J., Schrijvers, A.H.G.J., Brakkee, J.G.P., Davis, H.D., Scheper, R.J., Balm, A.J.M., Meijer, C.J.L.M., Snow, G.B., and van Dongen, G.A.M.S. Expression and characterization of two differentiation antigens in stratified epithelia and carcinomas. Int. J. Cancer, 50: 507-513, 1992.
14. Quak, J.J., van Dongen, G.A.M.S., Gerretsen, M., Hayashida, D., Balm, A.J.M., Brakkee, J.G.P., Snow, G.B., and Meijer, C.J.L.M. Production of a monoclonal antibody (K931) to a squamous cell carcinoma associated antigen identified as the 17-1A antigen. Hybridoma, 9: 377-387, 1990.
15. Schrijvers, A.H.G.J., Gerretsen, M., Fritz, J.M., van Walsum, M., Quak, J.J., Snow, G.B., and van Dongen, G.A.M.S. Evidence for a role of the monoclonal antibody E48 defined antigen in cell-cell adhesion in squamous epithelia and head and neck squamous cell carcinoma. Exp. Cell Res., 196: 264-269, 1991.
16. van Dongen, G.A.M.S., Leverstein, H., Roos, J.C., Quak, J.J., van den Brekel, M.W.M., van Lingen, A., Martens, H.J.M., Castelijns, J.A., Visser, G.W.M., Meijer, C.J.L.M., Teule, G.J.J., and Snow, G.B. Radioimmunoscintigraphy of head and neck cancer using 99mTc-labeled monoclonal antibody E48 F(ab’)2 Cancer Res., 52: 2569-2574, 1992.
17. Gerretsen, M., Schrijvers, A.H.G.J., van Walsum, M., Braakhuis, B.J.M., Quak, J.J., Meijer, C.J.L.M., Snow, G.B., and van Dongen, G.A.M.S. Radioimmunotherapy of human head and neck squamous cell carcinoma xenografts with 131I-labelled monoclonal antibody E48. Br. J. Cancer, 66: 496-502, 1992.
18. Goldrosen, M.H., Biddle, W.C., Pancook, J., Bakshi, S., Vanderheyden, J.L., Fritzberg, A.R., Morgan, A.C., Jr., and Foon, K.A. Biodistribution, pharmacokinetics and imaging studies with 186Re-labeled NR-LU-10 whole antibody in LS174T colonic tumor-bearing mice. Cancer Res., 50: 7973-7978, 1990.
19. Beaumier, P.L., Venkatesan, P., Vanderheyden, J.L., Burgua, W.D., Kunz, L.L., Fritzberg, A.R., Abrams, P.G., and Morgan, A.C., Jr. 186Re radioimmunotherapy of small cell lung carcinoma xenografts in nude mice. Cancer Res., 51: 676-681, 1991.
20. Najafi, A., Alauddin, M.M., Sosa, A., Ma, G.Q., Chen, D.C.P., Epstein, A.L., and Siegel, M.E. The evaluation of 186Re-labeled antibodies using N2S4 chelate in vitro and in vivo using tumor-bearing nude mice. Nucl. Med. Biol., 19: 205-212, 1992.
21. Breitz, H.B., Weiden, P.L., Vanderheyden, J.L., Appelbaum, J.W., Bjorn, M.J., Fer, M.F., Wolf, S.B., Ratlif, B.A., Seiler, C.A., Foisie, D.C., Fisher, D.R., Schroff, R.W., Fritzberg, A.R., and Abrams, P.G. Clinical experience with rhenium- 186-labeled monoclonal antibodies for radioimmunotherapy: results of phase I trials. J. Nucl. Med., 6: 1099-1109, 1992.
22. Goldenberg, D.M., and Griffiths, G.L. Radioimmunotherapy: arming the missiles. J. Nucl. Med., 33: 1110-1112, 1992.
23. Fritzberg, A.R., Abrams, P.G., Beaumier, P.L., Kasina, S., Morgan, A.C., Jr., Rao, T.N., Reno, J.M., Sanderson, J.A., Srinivasan, A., Wilbur, D.S., and Vanderheyden, J.L. Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent. Proc. Natl. Acad. Sci. USA, 85: 4025-4029, 1988.
24. Braakhuis, B.J.M., van Dongen, G.A.M.S., Bagnay, M., van Walsum, M., and Snow, G.B. Preclinical chemotherapy on human head and neck cancer xenografts grown in athymic nude mice. Head & Neck, 11: 511-515, 1989.
25. Gerretsen, M., Quak, J.J., Suh, J.S., van Walsum, M., Meijer, C.J.L.M., Snow, G.B., and van Dongen, G.A.M.S. Superior localization and imaging of radiolabeled monoclonal antibody E48 F(ab’)2 fragment in xenografts of human squamous cell carcinoma of the head and neck and of the vulva as compared to monoclonal antibody E48 IgG. Br. J. Cancer, 63: 37-44, 1991.
26. Lindmo, T., Boven, E., Cuttitta, F., Fedorko, J., and Bunn, P.A., Jr. Determination of the immunoreactive fraction of radiolabelled monoclonal antibodies by linear extrapolation to binding at infinite antigen excess. J. Immunol. Methods, 72: 77-89, 1984.
27. Badger, C.C., Krohn, K.A., Shulman, H., Flournoy, N., and Bernstein, I.D. Experimental radioimmunotherapy of murine lymphoma with 13lI-labeled anti-T cell antibodies. Cancer Res., 46: 6223-6228, 1986.
28. Dillman, L.T. Radionuclide Decay Schemes and Nuclear Parameters for Use in Radiation-Dose Estimation. MIRD Pamphlet-4. New York: The Society of Nuclear Medicine, 1969.
29. Edwards, D.P., Grzyb, K.T., Dressier, L.G., Mansel, R.E., Zava, D.T., Sledge, G.W., and McGuire, W.L. Monoclonal antibody identification and characterization of a Mr 43, 000 membrane glycoprotein associated with human breast cancer. Cancer Res., 46: 1306-1317, 1986.
30. Takahashi, H., Wilson, B., Ozturk, M., Motte, P., Straus, W., Isselbacher, K.J., and Wands, J.R. In vivo localization of human colon carcinoma by monoclonal antibody binding to a highly expressed cell surface antigen. Cancer Res., 48: 6573-6579, 1988.
31. Shikani, A.H., Richtsmeier, W.J., Klein, J.L., and Kopher, K.A. Radiolabeled antibody therapy for squamous cell carcinoma of the head and neck. Arch. Otolaryngol. Head Neck Surg., 118: 521-525, 1992.
32. Goldenberg, D.M. Challenges to the therapy of cancer with monoclonal antibodies. J. Natl. Cancer Inst., 83: 78-79, 1991.
33. Epenetos, A.A., and Kosmas, C. Monoclonal antibodies for imaging and therapy. Br. J. Cancer, 59: 152-155, 1989.
34. Chatal, J.F., Saccavini, J.C., Thedrez, P., Curtet, C., Kremer, M., Guerreau, D., Nolibe, D., Fumoleau, P., and Guillard, Y. Biodistribution of indium-111-labeled OC125 monoclonal antibody intraperitoneally injected into patients operated on for ovarian carcinomas. Cancer Res., 49: 3087-3094, 1989.